Dr. Avi Weisfogel is a New Jersey-based dentist. For over two decades of excellence and professional value, Dr. Avi Weisfogel has amassed a great amount of knowledge and experience solving people’s sleep apnea problems. Dr. Avi Weisfogel is one of the few dentists in the world who have developed numerous therapies that are adopted on a massive scale for use in treating sleep apnea. Dr. Avi Weisfogel has developed more than 100 therapies that are approved by the FDA for use in America. Because of his commitment towards medical excellence and finding the solution to sleep apnea, Dr. Avi Weisfogel is now one of the most reputable doctors based in New Jersey.
The American Medical Society adopted dr. Avi Weisfogel as one of the best dentist of the year in 2015. His recognition followed the fact that he had developed more than 100 therapies to treat the disease. For this reason, Dr. Avi Weisfogel developed the Dental Sleep Masters Company that works by treating sleep apnea medical patients in the industry. Dr. Avi Weisfogel has a strong commitment towards solving the problem associated with sleep apnea. When he completed his college education from the New York-based New York School of Medicine, Dr. Avi Weisfogel wanted to become one of the best dentists in the world. Little did he know that the way he would achieve that was to help adopt a new way of treating sleep apnea patients.
During his first week at the New Jersey Based Old Bridge Dental Practice, Dr. Avi Weisfogel was faced with the first case of sleep apnea. While he had little experience treating the illness, he wanted to solve the problem so that people would believe he is the best.
Sleep is one of the few things that are always overlooked when one has a busy schedule. However, it is one of the practices that affect your well-being in the future. Prolonged lack of sleep causes sleep apnea. It is also good to note that it is one of the most expensive illnesses to treat in the medical world. If you can, avoid it.
Jim tananbaum is the chief executive officer of Foresite Capital. He founded Foresite as a healthcare private equity firm in 2011 specializing in addressing emerging healthcare needs. The company helps health care leaders achieve growth in profits by supplying networks, information, and capital.
Before founding the company, Jim Tananbaum founded GelTex Pharmaceuticals, which supplied drugs to the market at $80 million. GelTex Pharmaceuticals supplies Renagel, which has annual revenue of at least $1billion today. Besides, GelTex Mr. Tananbaum co-founded Theravance Inc and later became the CEO. The company shares GSK respiratory franchise via a joint venture INVA: NASDAQ, which has a total market capitalization of $3.2 billion.
Jim has much investment experience including being the founding partner of both Prospect Venture Partners III and II. Early in his healthcare career, he was a partner at Seira Ventures and oversaw the establishment of the healthcare services investment practice in the company. Jim Tananbaum has championed several investments such as Amira Pharmaceuticals. Jazz Pharmaceuticals, Healtheon and Amerigroup. His vision is to merge elements of different aspects in his career and create a leading and stable investment platform.
Mr. Jim Tananbaum is a graduate of Yale with a degree in computer science and electrical engineering. He holds an M.B.A and M.D from Harvard. He has an M.S from Massecheussetts Institute of Technology. He has been passionate about the interdisciplinary marriage between computer science, hard sciences, and healthcare. He has several long-term relationships with various leading academicians.
George Whitesides, Rick Klausner, Bob Gunderson, Rick Levin and Roy Vagelos are some of his mentors and collaborators. He has a strong passion in advancing his evolution work across different industries with lead academicians and entrepreneurs. Mr. Jim Tananbaum believes that to achieve great growth and change, better insights in science and deep learning is necessary.
According to Wired, Foresite Capital is a product of his long-standing career as an investment strategist and healthcare entrepreneur. Several factors played a major role in his success and transformation approach behind the innovation. Foresite Capital demonstrates his ability to harness and understand the future of healthcare. The insight is because of the recognition the need for capital in healthcare solutions and innovative products. The company plays a major role in defusing what is necessary for determining viable healthcare investment prospects with a high degree of success.